Similar articles

• Evidence-based medication and revascularization: powerful tools in the management of patients with diabetes and coronary artery disease: a report from the Euro Heart Survey on diabetes and the heart.

  Anselmino M, Malmberg K, Ohrvik J, Rydén L; Euro Heart Survey Investigators. Anselmino M, et al. Eur J Cardiovasc Prev Rehabil. 2008 Apr;15(2):216-23. doi: 10.1097/HJR.0b013e3282f335d0. Eur J Cardiovasc Prev Rehabil. 2008. PMID: 18391651
• Atherothrombotic insights into secondary prevention after acute myocardial infarction.

  Rabbani LE, Loscalzo J. Rabbani LE, et al. Can J Cardiol. 1993 Oct;9(8):739-47. Can J Cardiol. 1993. PMID: 7903593 Review.
• How to improve the cardiac prognosis for diabetes.

  Herlitz J, Malmberg K. Herlitz J, et al. Diabetes Care. 1999 Mar;22 Suppl 2:B89-96. Diabetes Care. 1999. PMID: 10097907 Review.
• [Thrombolytic treatment of acute myocardial infarct. 3].

  Gabriel HM, Soares-Costa JT, Soares-Costa TJ. Gabriel HM, et al. Acta Med Port. 1998 May;11(5):431-8. Acta Med Port. 1998. PMID: 9951053 Review. Portuguese. No abstract available.
• [Primary and secondary prevention of coronary artery disease].

  Mohri M. Mohri M. Fukuoka Igaku Zasshi. 2003 Mar;94(3):43-7. Fukuoka Igaku Zasshi. 2003. PMID: 12784708 Review. Japanese. No abstract available.